4//SEC Filing
MERRIFIELD C ANN 4
Accession 0000899243-22-023341
CIK 0001327273other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:06 PM ET
Size
5.7 KB
Accession
0000899243-22-023341
Insider Transaction Report
Form 4
MERRIFIELD C ANN
Director
Transactions
- Award
Stock Option
2022-06-16+7,250→ 7,250 totalExercise: $5.09Exp: 2032-06-15→ Common Stock (7,250 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable on the earlier of (i) June 16, 2023 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001247224
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:06 PM ET
- Size
- 5.7 KB